Search Results

PMD Announces New ISIN Code and Timetable for Reverse Split of Shares

PMD Device Solutions In connection with the reverse share split, whereby 128 shares are combined into one new share, PMDS will receive a new ISIN code.

January 29, 2024

·

1 min read

Deals

Promore Pharma AB intends to carry out a reverse acquisition of PMD Device Solutions AB

Promore Pharma AB intends to acquire all the shares in PMD Device Solutions AB by making payment in the form of newly issued shares in the Company.

November 29, 2023

·

12 min read

Business

PMD – New Name and Ticker Symbol; Irish Minister To Attend Bell-Ringing Ceremony

Promore Pharma Following the reverse acquisition of Promore Pharma AB and change of name of the company from Promore Pharma AB to PMD Device Solutions AB the Company’s ticker symbol will change from PROMO to PMDS with effect from 17 January 2024.

January 16, 2024

·

2 min read

Deals

PMD Updates on the Reverse Share Split Following the Reverse Acquisition

Device Solutions AB formerly Promore Pharma AB, carried out the reverse acquisition with the PMD group by decision of the extraordinary general meeting on 29 December 2023 and simultaneously decided on a reverse share split.

January 16, 2024

·

2 min read

Press Releases

OMEICOS Therapeutics Completes Enrollment of PMD-OPTION Study in Primary Mitochondrial Disease

September 26, 2024

·

3 min read

Update on Reverse Acquisition - PMD Completes Private Placement and Major Shareholder Receives Exemption from Mandatory Bid Requirements

Promore Pharma AB announced on 29 November 2023 the reverse acquisition of PMD Device Solutions AB and PMD’s intended private placement of shares in PMD prior to the Reverse Acquisition.

December 8, 2023

·

5 min read

Promore Pharma AB (publ) has received approval for continued trading on Nasdaq First North Growth Market and publishes company description

Promore Pharma AB, under name change to PMD Device Solutions AB, has received approval for continued trading on Nasdaq First North Growth Market and publishes a company description prepared in connection with the name and business change of the Company as a result of the planned acquisition of PMD Device Solutions AB.

December 21, 2023

·

2 min read

Report from the Extraordinary General Meeting of Promore Pharma AB Held on 29 December 2023

Promore Pharma Promore Pharma AB, under change of name to PMD Device Solutions AB, held an extraordinary general meeting on Friday, 29 December 2023.

December 29, 2023

·

3 min read

Press Releases

Boehringer Ingelheim launches VETMEDIN® Solution (pimobendan oral solution), first oral solution approved by the FDA for congestive heart failure in dogs

November 25, 2024

·

6 min read

Press Releases

ELMCRx Solutions Offers Cell & Gene Therapy Support Through Partnership with Emerging Therapy Solutions (ETS)

December 12, 2024

·

3 min read